Eli Lilly applies for FDA emergency use of COVID-19 treatment

Eli Lilly and Co said on Wednesday it had submitted a request to the US Food and Drug Administration for emergency use of its experimental antibody treatment for COVID-19.
Separately, the US drugmaker said data from a new study showed a combination of two of its antibody treatments helped reduce hospitalization and emergency room visits for COVID-19 patients.
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy